North America Surgical Heart Valves Market Outlook to 2036 – Cardiac Valve Repair Devices and Prosthetic Heart Valves

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report Download FREE Resources

Published: April 27, 2026 Report Code: GDME21944CRDB-ST

Select Item

GlobalData’s “North America Surgical Heart Valves Outlook to 2036” is a comprehensive databook report, covering key market data on the North America Surgical Heart Valves market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Valve Repair Devices and Prosthetic Heart Valves

The North America Surgical Heart Valves Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
• 2025 company share data for Surgical Heart Valves Market.
• Global corporate-level profiles of key companies operating within the North America Surgical Heart Valves Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Surgical Heart Valves is segmented as follows:

• Cardiac Valve Repair Devices

• Prosthetic Heart Valves

Reasons to Buy

The North America Surgical Heart Valves Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

Table of Contents

List of Tables

List of Figures

1 Introduction

1.1 What Is This Report About?

1.2 Surgical Heart Valves Market Segmentation

1.3 Definitions of Markets Covered in the Report

2 Surgical Heart Valves Market, North America

2.1 Surgical Heart Valves Market, North America, Revenue ($m), 2024-2036

2.2 Surgical Heart Valves Market, North America, Revenue ($m), 2024-2036

2.3 Surgical Heart Valves Market, North America, Volume (Units), 2024-2036

2.4 Surgical Heart Valves Market, North America, Volume (Units), 2024-2036

2.5 Surgical Heart Valves Market, North America, Company Share by Revenue ($m), 2025

3 Surgical Heart Valves Market, Canada

3.1 Surgical Heart Valves Market, Canada, Revenue ($m), 2024-2036

3.1.1 Cardiac Valve Repair Devices Market, Canada, Revenue ($m), by Segment, 2024-2036

3.1.2 Prosthetic Heart Valves Market, Canada, Revenue ($m), by Segment, 2024-2036

3.2 Surgical Heart Valves Market, Canada, Volume (Units), 2024-2036

3.2.1 Cardiac Valve Repair Devices Market, Canada, Volume (Units), by Segment, 2024-2036

3.2.2 Prosthetic Heart Valves Market, Canada, Volume (Units), by Segment, 2024-2036

3.3 Surgical Heart Valves Market, Canada, Average Price ($), 2024-2036

3.4 Surgical Heart Valves Market, Canada, Company Share by Revenue ($m), 2025

4 Surgical Heart Valves Market, Mexico

4.1 Surgical Heart Valves Market, Mexico, Revenue ($m), 2024-2036

4.1.1 Cardiac Valve Repair Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036

4.1.2 Prosthetic Heart Valves Market, Mexico, Revenue ($m), by Segment, 2024-2036

4.2 Surgical Heart Valves Market, Mexico, Volume (Units), 2024-2036

4.2.1 Cardiac Valve Repair Devices Market, Mexico, Volume (Units), by Segment, 2024-2036

4.2.2 Prosthetic Heart Valves Market, Mexico, Volume (Units), by Segment, 2024-2036

4.3 Surgical Heart Valves Market, Mexico, Average Price ($), 2024-2036

4.4 Surgical Heart Valves Market, Mexico, Company Share by Revenue ($m), 2025

5 Surgical Heart Valves Market, United States

5.1 Surgical Heart Valves Market, United States, Revenue ($m), 2024-2036

5.1.1 Cardiac Valve Repair Devices Market, United States, Revenue ($m), by Segment, 2024-2036

5.1.2 Prosthetic Heart Valves Market, United States, Revenue ($m), by Segment, 2024-2036

5.2 Surgical Heart Valves Market, United States, Volume (Units), 2024-2036

5.2.1 Cardiac Valve Repair Devices Market, United States, Volume (Units), by Segment, 2024-2036

5.2.2 Prosthetic Heart Valves Market, United States, Volume (Units), by Segment, 2024-2036

5.3 Surgical Heart Valves Market, United States, Average Price ($), 2024-2036

5.4 Surgical Heart Valves Market, United States, Company Share by Revenue ($m), 2025

6 Surgical Heart Valves Market Pipeline Products

6.1 Surgical Heart Valves Market Pipeline Products

6.2 Surgical Heart Valves – Pipeline Products by Stage of Development

6.3 Surgical Heart Valves – Pipeline Products by Segment

6.4 Surgical Heart Valves – Pipeline Products by Territory

6.5 Surgical Heart Valves – Pipeline Products by Regulatory Path

6.6 Surgical Heart Valves – Pipeline Products by Estimated Approval Date

7 Overview of Key Companies in North America Surgical Heart Valves Market

7.1 Edwards Lifesciences Corp

7.1.1 Company Overview

7.2 Abbott Laboratories

7.2.1 Company Overview

7.3 Artivion Inc

7.3.1 Company Overview

7.4 Medtronic Plc

7.4.1 Company Overview

7.5 Corcym UK Ltd

7.5.1 Company Overview

8 Recent Developments

8.1 Corporate Communications

8.1.1 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System

8.1.2 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results

8.1.3 Nov 10, 2025: Dr. Felicitas Koller Named Inaugural Hardy-Raju Chair of Transplant Surgery

8.1.4 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

8.1.5 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager

8.1.6 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System

8.1.7 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

8.1.8 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption

8.1.9 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

8.1.10 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study

8.1.11 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System

8.1.12 Oct 15, 2025: Adagio Medical Prices $50 Million Private Placement of Securities

8.1.13 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction

8.1.14 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing

8.1.15 Sep 12, 2025: Cedars-Sinai Receives $26M to Research Heart Valve Disease

8.2 Financial Announcements

8.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

8.2.2 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results

8.2.3 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

8.3 Government and Public Interest

8.3.1 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting

8.4 Other Significant Developments

8.4.1 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months

8.4.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

8.4.3 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

8.4.4 Nov 03, 2025: News Updates for Q3 2025

8.4.5 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

8.4.6 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

8.4.7 Oct 16, 2025: Excision Of A Six-Year-Old Evolut CoreValve TAVR

8.4.8 Oct 15, 2025: Adagio Medical Prices $50 Million Private Placement of Securities

8.4.9 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting

8.4.10 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction

8.4.11 Sep 12, 2025: Cedars-Sinai Receives $26M to Research Heart Valve Disease

8.4.12 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products

8.5 Product News

8.5.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV

8.5.2 Nov 20, 2025: Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Clinical Results

8.5.3 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared

8.5.4 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months

8.5.5 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System

8.5.6 Nov 13, 2025: EnVVeno Faces FDA Rejection on VenoValve Application

8.5.7 Nov 12, 2025: VitAA Medical Receives FDA Clearance for AiORTA Plan in Aortic Care

8.5.8 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results

8.5.9 Nov 07, 2025: Gore Announces Positive Clinical Trial Results of the Investigational Gore Viabahn Fortegra Venous Stent for Treatment of Patients with Deep Venous Iliocaval Obstruction

8.5.10 Nov 06, 2025: Artivion Treats First Patient in ARTIZEN Trial for Arcevo LSA

8.5.11 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

8.5.12 Nov 05, 2025: Fluid Control Solutions For MedTech

8.5.13 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study

8.5.14 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study

8.5.15 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

8.5.16 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy

8.5.17 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System

8.5.18 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma

8.5.19 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

8.5.20 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption

8.5.21 Oct 27, 2025: Successful Patient Outcomes With Edwards’ SAPIEN M3 and EVOQUE Systems

8.5.22 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study

8.5.23 Oct 24, 2025: Protaryx Medical Submits 510(k) Application for Next-Generation Transseptal Puncture Device

8.5.24 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System

8.5.25 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter

8.5.26 Oct 15, 2025: Adagio Medical Prices $50 Million Private Placement of Securities

8.5.27 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing

8.5.28 Oct 01, 2025: Adagio Medical Completes Enrollment in FULCRUM-VT Clinical Trial for Ventricular Tachycardia

8.5.29 Sep 28, 2025: Acoramidis Reduces Cardiovascular Outcomes in ATTR-CM Patients Within the First Month

8.5.30 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products

8.6 Strategy And Business Planning

8.6.1 Nov 09, 2025: Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease

8.6.2 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.

8.6.3 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics

8.6.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

9 Appendix

9.1 Research Methodology

9.1.1 Coverage

9.1.2 Secondary Research

9.1.3 Primary Research

9.1.4 Market Modeling and Forecasting

9.1.5 Company Share Analysis

9.1.6 Benchmarking

9.2 GlobalData Consulting

9.3 Contact Us

9.4 Disclaimer

Table

Table 1: Surgical Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Table 2: Surgical Heart Valves Market, North America, Revenue ($m), USD Constant, 2024-2036

Table 3: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036

Table 4: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036

Table 5: Surgical Heart Valves Market, North America, Company Share by Revenue ($m), 2025

Table 6: Surgical Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 7: Cardiac Valve Repair Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 8: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 9: Surgical Heart Valves Market, Canada, Volume (Units), 2024-2036

Table 10: Cardiac Valve Repair Devices Market, Canada, Volume (Units), 2024-2036

Table 11: Prosthetic Heart Valves Market, Canada, Volume (Units), 2024-2036

Table 12: Surgical Heart Valves Market, Canada, Average Price ($), 2024-2036

Table 13: Surgical Heart Valves Market, Canada, Company Share by Revenue ($m), USD Constant, 2025

Table 14: Surgical Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 15: Cardiac Valve Repair Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 16: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 17: Surgical Heart Valves Market, Mexico, Volume (Units), 2024-2036

Table 18: Cardiac Valve Repair Devices Market, Mexico, Volume (Units), 2024-2036

Table 19: Prosthetic Heart Valves Market, Mexico, Volume (Units), 2024-2036

Table 20: Surgical Heart Valves Market, Mexico, Average Price ($), 2024-2036

Table 21: Surgical Heart Valves Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025

Table 22: Surgical Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 23: Cardiac Valve Repair Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 24: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 25: Surgical Heart Valves Market, United States, Volume (Units), 2024-2036

Table 26: Cardiac Valve Repair Devices Market, United States, Volume (Units), 2024-2036

Table 27: Prosthetic Heart Valves Market, United States, Volume (Units), 2024-2036

Table 28: Surgical Heart Valves Market, United States, Average Price ($), 2024-2036

Table 29: Surgical Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2025

Table 30: Surgical Heart Valves Market Pipeline Products

Table 31: Surgical Heart Valves – Pipeline Products by Stage of Development

Table 32: Surgical Heart Valves Companies – Pipeline Products by Stage of Development

Table 33: Surgical Heart Valves – Pipeline Products by Segment

Table 34: Surgical Heart Valves – Pipeline Products by Territory

Table 35: Surgical Heart Valves – Pipeline Products by Regulatory Path

Table 36: Surgical Heart Valves – Pipeline Products by Estimated Approval Date

Table 37: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figures

Figure 1: Surgical Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Figure 2: Surgical Heart Valves Market, North America, Revenue ($m), USD Constant, 2024-2036

Figure 3: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036

Figure 4: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036

Figure 5: Surgical Heart Valves Market, North America, Company Share (%), 2025

Figure 6: Surgical Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 7: Cardiac Valve Repair Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 8: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 9: Surgical Heart Valves Market, Canada, Volume (Units), 2024-2036

Figure 10: Cardiac Valve Repair Devices Market, Canada, Volume (Units), 2024-2036

Figure 11: Prosthetic Heart Valves Market, Canada, Volume (Units), 2024-2036

Figure 12: Surgical Heart Valves Market, Canada, Company Share (%), 2025

Figure 13: Surgical Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 14: Cardiac Valve Repair Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 15: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 16: Surgical Heart Valves Market, Mexico, Volume (Units), 2024-2036

Figure 17: Cardiac Valve Repair Devices Market, Mexico, Volume (Units), 2024-2036

Figure 18: Prosthetic Heart Valves Market, Mexico, Volume (Units), 2024-2036

Figure 19: Surgical Heart Valves Market, Mexico, Company Share (%), 2025

Figure 20: Surgical Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 21: Cardiac Valve Repair Devices Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 22: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 23: Surgical Heart Valves Market, United States, Volume (Units), 2024-2036

Figure 24: Cardiac Valve Repair Devices Market, United States, Volume (Units), 2024-2036

Figure 25: Prosthetic Heart Valves Market, United States, Volume (Units), 2024-2036

Figure 26: Surgical Heart Valves Market, United States, Company Share (%), 2025

Figure 27: Surgical Heart Valves – Pipeline Products by Stage of Development

Figure 28: Surgical Heart Valves – Pipeline Products by Segment

Figure 29: Surgical Heart Valves – Pipeline Products by Territory

Figure 30: Surgical Heart Valves – Pipeline Products by Regulatory Path

Figure 31: Surgical Heart Valves – Pipeline Products by Estimated Approval Date

North America Surgical Heart Valves Market Outlook to 2036 – Cardiac Valve Repair Devices and Prosthetic Heart Valves standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

North America Surgical Heart Valves Market Outlook to 2036 – Cardiac Valve Repair Devices and Prosthetic Heart Valves was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Medical Devices
New
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…
$7,500 | May 2026
Medical Devices
New
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Surgical Heart Valves Market Outlook to 2036 – Cardiac Valve Repair Devices and Prosthetic Heart Valves in real time.

  • Access a live North America Surgical Heart Valves Market Outlook to 2036 – Cardiac Valve Repair Devices and Prosthetic Heart Valves dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more